Medicure

Medicure EBITDA per Share

The EBITDA per Share of Medicure (MPH.V) as of Nov 16, 2026 is -0.66 CAD. In the previous year, EBITDA per Share was -0.15 CAD — a change of 335.12% (lower).

EBITDA per Share

-0.66CAD

YoY

335.12%

Last updated:

EBITDA per Share of Medicure is 2025 -0.66 CAD. EBITDA per Share of Medicure was 2024 -0.15 CAD. It decreases by 335.12% lower compared to the previous year.

The Medicure EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.08 CAD
Jan 1, 2019
-0.68 CAD
Jan 1, 2020
-0.68 CAD
Jan 1, 2021
0.25 CAD
Jan 1, 2022
0.24 CAD
Jan 1, 2023
0.05 CAD
Jan 1, 2024
-0.15 CAD
Jan 1, 2025
-0.66 CAD
The Medicure EBITDA per Share history
YEAREBITDA per ShareYoY
-0.66CAD+335.12%
-0.15CAD-400.38%
0.05CAD-79.17%
0.24CAD-3.31%
0.25CAD-136.82%
-0.68CAD-0.30%
-0.68CAD+779.49%
-0.08CAD-133.25%
0.23CAD-47.57%
0.45CAD+27.03%
0.35CAD+336.20%
0.08CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medicure Stock analysis

What does Medicure do? Medicure Inc. is a pharmaceutical company specializing in the development of medications for cardiovascular diseases. The company was founded in 1997 and is headquartered in Winnipeg, Canada. Medicure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicure stock

EBITDA per Share of Medicure is -0.66 CAD in 2025.

EBITDA per Share of Medicure changed from -0.15 CAD to -0.66 CAD, representing a 335.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Medicure since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Medicure

All Key Metrics — Medicure